key: cord-0945069-3m5gel4a authors: Lertkhachonsuk, Arb-aroon; Charoenkwan, Kittipat; Wilailak, Sarikapan; Kasemsarn, Panon; Srisomboon, Jatupol title: The 7th Biennial Meeting of the Asian Society of Gynecologic Oncology, November 25th to 27th, 2021 date: 2022-01-27 journal: J Gynecol Oncol DOI: 10.3802/jgo.2022.33.e36 sha: 8782baad4546d84c44aa4c4eb0e84a8570dc65c6 doc_id: 945069 cord_uid: 3m5gel4a nan The Asian Society of Gynecologic Oncology (ASGO) was inaugurated in 2008 as the expansion of the former Japan-Korea Joint Conference of Gynecologic Oncology Group to include all Asian countries with the purpose of facilitating scientific exchanges, collaborating for clinical and basic researches, providing educational opportunities for doctors from developing countries and deepening friendships among Asian members, in order to ultimately improve the standard of practice and outcomes of Asian gynecologic cancer patients [1, 2] . Currently gynecologic oncologists from various countries have joined, with collaborations between 11 national gynecologic oncology societies in Asia. Film Poster Total Thailand 1,019 9 14 4 5 42 74 Taiwan 127 4 1 1 -2 8 Korea 122 14 9 14 1 25 63 Japan 102 15 11 6 2 13 47 India 80 3 3 3 -15 24 Indonesia 38 -1 --10 11 China 33 7 10 5 -10 32 Singapore 25 4 2 1 -1 8 Philippines 22 1 Egypt 1 1 --1 1 3 Iran 1 ------Italy 1 ------Kenya 1 ------Malaysia 1 1 1 ---2 Nepal 1 -1 ---1 Netherland 1 --1 --1 Paraguay 1 ------Saudi Arabia 1 ------Spain 1 --1 --1 Sweden 1 1 ----1 Switzerland 1 1 ----1 Sri Lanka 1 ------Total 1,654 77 54 37 10 120 Eleven speakers gave their lectures in 3 plenary sessions. The first plenary session addressed the current situations of minimally invasive surgery (MIS) in gynecologic cancer, with Masaaki Andou discussing the current situation of MIS in endometrial cancer, Chyi-Long Lee and Joseph Ng discussing the roles of MIS in cervical cancer using laparoscopic and robotic surgery, respectively. The second plenary session updated on the optimal management of recurrent ovarian cancer, with Andreas du Bois, Jonathan Ledermann and Sook-Hee Hong talked on the role of secondary cytoreduction, PARP inhibitor maintenance and targeting DNA damage repair, respectively. The third plenary session was a joint session between ASGO and the Asia-Oceania Research Organisation in Genital Infection and Neoplasia which emphasized on the national strategies for comprehensive cervical cancer control, with perspectives from India, Korea, Thailand, Australia, and the Philippines. Twelve speakers shared their expertise in 4 symposia. The first one was pathology session clarifying what's new in 2020 World Health Organization (WHO) classification of cervical, ovarian and uterine cancer. In the second symposium, 3 experts shared the strategies, roles and cost-utility of genetic testing in Malaysia, Singapore, and Korea. In the third symposium concerning onco-fertility, various advanced techniques for fertility preservation in women with gynecologic cancer were presented, including ovarian and uterine preservation. The fourth symposium set a stage for a debate on the future of MIS for early-stage cervical cancer, with Pedro Ramirez on the 'final' side and Hiroyuki Kanao on the 'continuum' side and Zhiqing Liang shared data from China based on national multicenter study and technology improvement. There were 8 special sessions, including many collaborative sessions between international organizations. 1) Asian practice guidelines for gynecologic cancers. Current guidelines for management of abnormal cervical screenings, adjuvant treatment of endometrial cancer, laparoscopic surgery for cervical cancer and management of advanced ovarian cancer were discussed with special considerations for the Asian population 2) WHO session on global mission of elimination of cervical cancer. Global health care leaders in the field of women's health including Nathalie Broutet, Acting Unit Head of WHO's Department of Sexual Health and Reproductive Cancers, Kazunori Ochiai, President of Asia & Oceania Federation of Obstetrics and Gynaecology (AOFOG), and Karun Kengsakul, President of the Royal Thai College of Obstetricians and Gynaecologists, discussed the global, regional and national strategies implemented to eliminate cervical cancer (Fig. 3) . 7th Biennial Meeting of the ASGO 5/9 https://ejgo.org delivered their opening remarks then session explored from basic concept of surgery and training to the trends and future perspectives in Asia and the US. The session ended with closing remarks from Pisake Lumbiganon, the President-elect of AOFOG (Fig. 4) . 6 ) In major clinical research advances in gynecologic cancer in 2021, the ever popular session similar to the article of the same name in JGO, key studies of the year were reviewed, covering cervical, uterine, ovarian and other rare cancers. 7) JGO session is also a regular session in ASGO, giving lessons on research planning and methodology. This year, the speakers gave advices on how to become a big paper author, how to conduct researches using cancer registration data and warned on misconducts in medical writing. There were 2 educational sessions. In the first one, gestational trophoblastic disease was comprehensively reviewed, from hydatidiform mole to low-and high-risk gestational trophoblastic neoplasia. In the second educational session, current and novel strategies to optimize outcomes of concurrent chemoradiation therapy for locally advanced cervical cancer was thoroughly considered, from surgical staging, neoadjuvant chemotherapy, radiation technique to targeted therapy. The 2 tumor board sessions comprised case discussions on the management of early and advanced endometrial cancers and cervical neuroendocrine carcinoma. In the closing ceremony, Professor Daisuke Aoki announced the awards for 5 best oral presentations, 4 best abstracts and 5 young gynecologic oncologists. Then, the next President of ASGO, Professor Jae-Weon Kim was introduced and delivered his speech. Professor Yang Xiang introduced the next ASGO International Workshop, which will be held in Qingdao, China, in conjunction with China Medical Association's annual meeting on gynecologic oncology, operating by Chinese Society of Gynecologic Oncology (Fig. 5 ). The 17th ASGO Council Meeting was held online on November 24th, 2021. Professor Jae-Weon Kim took over the President of ASGO from Professor Daisuke Aoki and Professor Sarikapan Wilailak was appointed as the next Vice-president. Professor Masaki Mandai was elected as President-elect. Taipei, Taiwan was chosen as the venue for the 8th Biennial Meeting in 2023. (Fig. 6) Asian Society of Gynecologic Oncology (ASGO): a new society for doctors working against gynecologic cancers in Asia Asian Society of Gynecologic Oncology (ASGO): a central platform against gynecologic cancers in Asia ASGO's First Biennial Meeting ASGO's Second Biennial Meeting ASGO's Third Biennial Meeting ASGO's Fourth Biennial Meeting The 5th Biennial Meeting of the Asian Society of Gynecologic Oncology The 6th Biennial Meeting of the Asian Society of Gynecologic Oncology, October 10th to 12th The authors would like to thank Professor Sarikapan Wilailak for her kind provision of the Council Member Meeting information. exchange scientific knowledge and strengthen international friendships per the ultimate aim of ASGO that is to improve the health of our gynecologic oncology patients.